Literature DB >> 17369922

Cell therapy of comatose states.

V I Seledtsov1, S S Rabinovich, O V Parlyuk, O V Poveshchenko, S V Astrakov, D M Samarin, G V Seledtsova, V V Senyukov, V Ya Taraban, V A Kozlov.   

Abstract

We demonstrated that liquor from adult humans can maintain proliferative activity of cells of immature nervous tissue in vitro. The paper presents the results of a retrospective clinical study of the efficiency of cell therapy in the treatment of II-III degree comatose patients with severe brain injury. Cell suspension consisting of cells derived from immature nervous and hemopoietic tissues was injected into the recipient subarachnoidal space through a cerebrospinal puncture. The mortality in the study group was 8% vs. 56% in the control group. The 1.5-year follow-up demonstrated significantly better quality of life in patients receiving cell therapy in comparison with patients of the control group. Cell therapy proved to be ineffective for patients in a comatose state caused by hypoxic encephalopathy. The study demonstrated the efficiency of cell therapy in patients with severe brain injury during the acute period of the disease.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17369922     DOI: 10.1007/s10517-006-0310-1

Source DB:  PubMed          Journal:  Bull Exp Biol Med        ISSN: 0007-4888            Impact factor:   0.804


  3 in total

Review 1.  Treatment of spinal cord injury by transplantation of cells via cerebrospinal fluid.

Authors:  Yan Liu; Hong-Yun Huang
Journal:  Neurosci Bull       Date:  2008-10       Impact factor: 5.203

2.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

3.  A Narrative Review of Pharmacologic and Non-pharmacologic Interventions for Disorders of Consciousness Following Brain Injury in the Pediatric Population.

Authors:  Nathan K Evanson; Andrea L Paulson; Brad G Kurowski
Journal:  Curr Phys Med Rehabil Rep       Date:  2016-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.